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Objective: This study investigates the role of various flow conditions on 
maternal hemodynamics during fetal cardiopulmonary bypass. Methods: 
Normothermic fetal bypass was conducted under pulsatile, or steady flow, 
for a 60-minute period. Fetal lamb preparations were randomly assigned to 
1 of the 3 groups: steady flow (n = 7), pulsatile flow (n = 7), or pulsatile 
blocked flow bypass (n = 7), where fetuses were perfused with N~°-nitro-L  
arginine after the first 30 minutes of pulsatile flow to assess the potential 
role of endothelial autacoids. Results: Maternal oximetry and pressures 
remained unchanged throughout he procedure. Under fetal pulsatile flow, 
maternal cardiac output increased after 20 minutes of bypass and remained 
significantly higher than under steady flow at minute 30 (8.8 - 0.7 L .  min -~ 
vs 5.9 - 0.5 L .  min -I, P = .02). Maternal cardiac output in the pulsatile 
group also remained higher than in both steady and pulsatile blocked flow 
groups, reaching respectively 8.7 -+ 0.9 L" min -1 vs 5.8 - 0.4 L. min -1 (P = 
.02) and 5.9 - 0.3 L .  rain -1 (P = .01) at minute 60. Maternal systemic 
vascular resistances were significantly lower under puisatile than under 
steady flow after 30 minutes and until the end of bypass (respectively, 9.1 - 
0.6 IU vs 12.7 ± 1.1 IU, P = .02 and 8.9 "4- 0.5 IU vs 12.9 --- 1.2 IU, P = .01). 
Infusion of N%nitro-L-arginine was followed by an increase in systemic 
vascular resistances from 9.3 ± 0.7 IU, similar to that of the pulsatile 
group, to 13.5 ± 1 IU at 60 minutes, similar to that of the steady flow group. 
Conclusions: Maternal hemodynamic changes observed under fetal pulsatile 
flow are counteracted after infusion of N'°-nitro-L-arginine, suggesting 
nitric oxide release from the fetoplacental unit under pulsatile fetal flow 
conditions. (J Thorac Cardiovasc Surg 1998;116:432-9) 
D uring normal pregnancy, maternal hemody- namic changes are well documented, such as the 
increase in cardiac output (CO), kidney blood flow, 
and glomerular filtration. 1 The observed reduction 
in blood pressure is caused by vasodilation and 
changes of the vascular tone and reactivity, medi- 
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ated by gestational hormonal activity like the pro- 
duction of vasodilator prostaglandins by the utero- 
placental unit or the decrease in vascular eaction to 
vasoconstrictive factors like angiotensin. 2' 3 Interac- 
tions between maternal nd fetal circulations are 
exacerbated under pathologic onditions like hyper- 
tension and preeclampsia, associated with increased 
risks to both the mother and the fetus. Similarly fetal 
distress may result from unbalanced placental flows 
under maternal bypass, which is sometimes per- 
formed for the correction of maternal valvular heart 
disease during pregnancy? On the other hand, given 
the recent improvements in antenatal diagnosis, 
some congenital heart defects might be amenable to 
intrauterine correction, necessitating the establish-- 
ment of fetal cardiopulmonary bypass. Experimen- 
tally, fetal bypass is usually poorly tolerated, unless 
some pharmacologic support is used. 5-9 
In previous experiments, we had demonstrated 
that the use of puisatile flow bypass may help to 
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, ~ -  7 fetuses under PBF bypass 
14 fetuses under PF (PF and N m Nitro L Arginine injection) 
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21 pregnant ewes  7 fetuses under PF bypass 
~ 7 fetuses under SF bypass 
Fig. 1. Experimental protocol. *Administration ofACH to fetuses after 40 min of bypass (T8) and to ewes 
after the end of fetuses bypass (TI1). $ N-NA injection in the PBF group after 30 minutes of bypass. 
prevent he onset of fetal hypoxia in this setting. 1°' 11 
More specifically, we had commonly observed that 
during a 30-minute period of fetal bypass, maternal 
blood pressure was usually lower under pulsatile 
flow than under steady flow. But in this fetal lamb 
preparation, the maternal hemodynamic status was 
not precisely monitored, particularly maternal blood 
flows and resistances. Finally, to the best of our 
knowledge, the effects of fetal bypass on maternal 
hemodynamics have not been investigated. 
The aim of the present study was to assess the 
effects of fetal pulsatile flow as compared with fetal 
steady flow bypass on maternal hemodynamics. Be- 
cause stimulation of nitric oxide (NO) endothelial 
Cell synthesis has been well described under high 
shear stress situations in arteries, like during pulsa- 
tile flow, 1244 the secondary end point of the study 
was to evaluate the potential impact of endotheli- 
urn-derived vasoactive substance release on mater- 
nal hemodynamic parameters under various fetal 
bypass flow conditions. 
Materials and methods 
All procedures and protocols performed in this study 
were approved by the local Animal Care Committee and 
in compliance with the Guide of the National Veterinary 
School for Laboratory animal studies. 
Anesthesia nd hemodynamic monitoring. Twenty-one 
mixed-breed "Grivette" ewes between 125 and 142 days 
gestation were fasted for 24 to 48 hours before the 
operation. The animals were placed in the supine position 
on an operating table after induction of anesthesia with 
diazepam (0.25 rag" kg J) and ketamine (5 rng.kg -1) 
intravenously administered in the jugular vein. Ewes were 
endotracheally intubated and connected to a volume- 
cycled respirator (MMS 107 ventilator; Bioms, Pau, 
France) with a 10-cyele/min respiratory rate and a 15 
ml • kg 1 tidal volume, with nitrous oxide/oxygen simulta- 
neously administered ata flow rate intended to keep the 
arterial oxygen saturation at 99% and the arterial carbon 
dioxide tension (Pco2) within normal limits. Anesthesia 
was maintained with 1% to 1.5% inspired halothane 
supplied by a Fluotec vaporizer (Ohmeda Health Care, 
West Yorkshire, England). Expired gases (oxygen, carbon 
dioxide, NO, halothanc) were continuously monitered 
using a Hewlett-Packard analyzer (HP M1015B; Br0n, 
France) to adjust volume and percentage of inspired gases 
for an optimal ventilation. 
Sheep were instrumented with a pulmonary artery 
flow-directed thermodilution catheter (Abbott Laborato- 
ries, Rungis, France) inserted percutaneously via an 8F 
introducer set (USCI Hemaquet, Baxter, Galway, Ireland) 
in the right jugular vein and up to the pulmonary artery. 
An arterial line was introduced in the femoral artery 
through a cutdown for maternal blood pressure monitor- 
ing and gas sampling. CO was measured with an 
Oxymetrix 3 computer (Abbott Laboratories, Rungis, 
France) by the thermodilution technique, performed in 
triplicate, with a 10 ml cold crystalloid bolus injection, 
recording the average value CO. Systemic and pulmonary 
vascular resistances were calculated by standard formulas. 
Another large-bore intravenous catheter (16-gauge) was 
inserted in the left jugular vein for fluid infusion to 
maintain adequate uterine perfnsion and to avoid fetal 
and maternal hypoglycemia. Maternal and fetal hemody- 
namic parameters were continuously monitored with Bax- 
ter transducers (Uniflow pressure set; Baxter Healthcare, 
Maurepas, France) and a multichannet recorder (Kone 
Corporation Instrument Division, Espoo, Finland). Blood 
gases sampled from maternal femoral artery were 
4 3 4 Vedrinne et al. 
The Journal of Thoracic and 
Cardiovascular Surgery 
September 1998 
Table I. Values of maternal blood gasses before and during bypass 
Pao2 Paco2 
Time Group pH (rnm Hg) (ram Hg) Sao 2 (%) 
After induction (TO) SF 7.38 ± 0.02 169 ± 37 32 + 4 94 ± 3 
PF 7.35 + 0.03 149 -+ 20 34 + 3 97 ± 1 
PBF 7.39 ± 0.04 165 ± 20 35 + 3 98 ± 1 
Before bypass (T3) SF 7.42 + 0.07 148 ± 37 36 ± 5 94 + 2 
PF 7.38 ± 0.05 119 ± t2 35 ~- 5 96 ± 1 
PBF 7.41 ± 0.04 161 + 25 39 + 4 97 +_ 1 
10-Min bypass (T4) SF 7.46 ± 0.07 144 + 29 31 ± 6 96 ± 2 
PF 7.37 ± 0.07 128 ± 16 36 m 6 96 ± 1 
PBF 7.41 _+ 0.04 149 4- 23 37 _+ 3 97 ÷ 1 
30-Min bypass (T6) SF 7.46 ± 0.07 167 ± 38 33 ~- 6 96 ± 2 
PF 7.37 ± 0.06 147 + 33 36 + 6 97 ± i 
PBF 7.42 ± 0.03 144 + 26 35 ± 2 97 ± 1 
40-Min bypass (T8) SF 7.48 + 0.08 162 ± 35 31 ± 7 96 ± 2 
PF 7.37 ± 0.06 139 ± 31 38 ± 7 96 + 1 
PBF 7.42 _+ 0.03 134 ± 23 37 ~+ 2 96 _+ 1 
60-Min bypass (Tll) SF 7.48 ±_ 0.08 165 _+ 34 30 ± 7 96 +_ 2 
PF 7.39 ± 0.05 145 + 33 33 -+ 5 97 ± t 
PBF 7.41 ± 0.04 135 + 26 35 _+ 2 96 ± ] 
All data are mean + SEM. 
immediately analyzed (PAP2, Pacos, and pH values) on a 
Radiometer 2400 gas analyzer (ABL 330, Radiometer 
Copenhagen, Copenhagen, Denmark). 
Hemodynamic and oximetric data were collected after 
induction of anesthesia (TO), 10 minutes before onset of 
bypass (T3), every 10 minutes after the initiation of bypass, 5 
minutes after the fetal N°'-nitro-L-arginine (N-NA) bolus 
injection (T7), and immediately after fetal (T9) and maternal 
injection (T12) of acetylcholine chloride (ACH). Measure- 
ment of fetal urinary excretion of NO metabolite and of 
maternal venous endothelin-1 concentration were per- 
formed in the 3 groups at the end of the procedure. 
Hemoglobin concentration was measured on an hemoglobin 
photometer (Hemocue, Angelholm, Sweden). 
Surgical procedure. After the uterus was exposed 
through a low midline laparotomy and a small hysterot- 
pray, fetal surgery was carried out according to a previ- 
ously described techniqueJ  ° Ketamine (50 mg) was ad- 
ministered intramuscularly to the fetus. Through a fetal 
neck incision, catheters were inserted into the common 
carotid artery for blood pressure monitoring and blood 
sampling and into the jugular vein for fetal perfusion. 
After a fetal midline sternotomy, normothermic bypass 
was instituted between pulmonary artery and right atrium 
cannulation. The bypass circuit consisted of a bubble 
oxygenator (Optiflow II; Cobe Laboratories inc., Lake- 
wood, Colo.) and a venous reservoir primed with 700 ml of 
freshly drawn heparinized adult sheep donor blood di- 
luted with 300 ml of Ringer's lactate. Bypass was con- 
ducted for a 60-minute period with a centrifugal pump 
(Delphin If centrifugal system; Sarns/3M Health Care, 
Ann Arbor, Mich.) set to deliver either pulsatile or steady 
flow. After the onset of bypass, the fetal heart was 
electrically fibrillated to rule out any contribution of the 
heart to the bypass flow and pulsatility. In each experi- 
ment the pump flow was adjusted to deliver a fetal mean 
blood pressure within the physiologic range of 45 to 50 
mm Hg. After cessation of bypass, the fetus was killed and 
weighed. A fetus urinary sample was collected through a 
bladder puncture. The ewe was then allowed to recover 
under antibiotic prophylaxis, associating penicillin and 
colistin intramuscularly delivered. 
Drug preparation. Immediately before each experi- 
ment, N-NA, 450 mg (Sigma Chemical, St. Quentin 
Falavier, France) was dissolved in a solution of 45 ml of 
0.9% sodium chloride (NaCI). Acetylcholine chloride, 10 
mg (Sigma Chemical) was diluted in one liter of NaCI, 1 
ml representing 10/xg. 
Endothelin-1 and NO metabolite measurements. Arte- 
rial blood samples (4.5 ml) were withdrawn into EDTA 
glass tubes after the end of bypass in all animals and 
immediately stored in ice. Blood samples were then 
centrifuged at 1250g and 4 ° C for 10 minutes, drawn up, 
and stored at -20°C until assayed. Plasma levels of 
endothelin-1 were determined by radioimmunoassay. 15 
Fetal urinary samples were immediately stored at -20 ° C. 
Nitrate assays were measured in fetal urine by dilution 
with distilled water and incubation with nitrate reductase 
and flavine adenosine. 16 
Protocol. The ewes (n = 21) were randomly allocated 
into 1 of the 3 groups, according to the type of fctal 
bypass, either steady flow (SF group, n = 7), pulsatile flow 
(PF group, n = 7), or pulsatile blocked flow (PBF group, 
n = 7). To test a potential modification of the vascular 
endothelium release of vasoactive substances under pul- 
satile flow conditions (Fig. 1), fetuses in the third group 
were perfused with N-NA, a stereospecific endothelium- 
derived relaxing factor synthesis inhibitor.17 Fetuses in the 
PBF group received a bolus injection of the diluted N-NA 
solution (20 rag. kg-l), slowly injected in the jugular vein 
after 30 minutes of bypass, followed by a 20 mg. kg -1 • hr -~ 
continuous infusion for the next 30 minutes to the end of 
bypass. In previous studies, this dose had been shown to 
block NO production] 7 To determine the effectiveness of 
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Table II. Maternal hemodynamic 
MABP CVP MPAP PA OP 
Group HR (ram Hg) (ram Hg) (ram Hg) (ram Hg) 
Af ter  induct ion  (TO) SF 108 _+ 9 84 + 4 9 +_ 1 16 + 1 11 _+ 1 
PF  102_  + 2 86-+5 8 + _ 1 16 + 1 10+- 1 
PBF  113_+9 83±4 9± 1 17 +2 11 +1 
Before  bypass (T3) SF 119 +- 13 79 ± 3 7 ± 1 16 + 1 8 -+ 1 
PF  110_+9 88±5 7-+ 1 14_+ 1 10-+1 
PBF  116+-9  84±5 6-+ 1 17±2 12 +2 
10-Min bypass (T4) SF 118 -+ 11 78 ± 3 6 + 5 15 ± 1 9 + 1 
PF  113 +- 10 84 ± 5 6 -+ 1 16 + 1 10 + 1 
PBF  116±7 83±5 6-+ l 15 -+1 9 -+1 
30-Min bypass (T6) SF 122 ± 10 79 ± 3 6 -+ 1 14 -+ 1 9 + 1 
PF  118_+5 85±6 7+ 1 16±2 10 +1 
PBF  119-+9 85±5 7±1 14-+1 10 +1 
40-Min bypass (TS) SF 118 _+ 5 79 -+ 3 7 -+ I 15 + 1 8 + 1 
PF  122 _+ 10 81 ± 6 7 -+ 1 16 + 2 10 + 1 
PBF  118 +- 12 85 + 6 7 _+ 1 15 + I ]0 + 1 
60-Min bypass (T l l )  SF 119 _+ 9 79 ± 3 7 ± ] 13 -+ 2 10 + 1 
PF  114 _+ 10 82+6 7 -+ 1 15 + 1 8 + 1 
PBF  120_+8 87-+6 8-+ 1 15 +1 10-+1 
All data are mean + SEM. 
HR, Heart rate; CVP, central venous pressure; MPAP, mean pulmonaly artery blood pressure; PAOP, pulmonary artenj occlusive pressure. 
subsequent maternal and fetal NO blockade caused by 
N-NA, the hemodynamic response to an intact endothelium- 
dependent vasodilator, such as ACH (45 leg), was evaluated: 
fetal ACH jugular venous injection was performed immedi- 
ately after minute 40 of bypass, whereas maternal ACH 
venous injection was made shortly after the end of bypass to 
prevent maternal hemodynamic destabilization. 
Statistical analysis. Data were stored on a spreadsheet 
database with a Power Macintosh 7600/132 (Apple Com- 
puters, Inc., Cupertino, Calif.) and analyzed with a statis- 
tical package (Statview; Abacus Concept, Inc., Berkeley, 
Calif.). Values were expressed as mean + SEM. A 
repeated-factor ANOVA test was made to compare one 
after the other, all the hemodynamic variables and all the 
blood gas measurements in the 3 group with a PLSD 
Fisher test if necessary. When intergroup variability was 
assessed by repcated-measures analysis of variance, we 
performed the nonparametric test of Kruskal and Wallis 
on specific means at TO, T3, T4, T6, 40 minutes of bypass 
(TS), and the end of bypass (TI1) with a post hoc testing 
of Bonferroni/Dunn. Nonparametric Wilcoxon test was 
used to compare paired values and to determine the effect 
of N-NA or ACH infusion. Plasma maternal endothelin 
levels and urina U nitrate and nitrite values were com- 
pared with the Kruskal-Wallis test. Statistical significance 
was established at the 5% level. 
Results 
The 3 groups were comparable as regard to the 
average weight of ewes (55 -+ 6 kg) and fetuses 
(3.9 ± 0.2 kg) and the gestation weight (7.8 ± 3.3 
kg) and mean number of fetuses (2 _+ 0.1). 
The maternal values of arterial pH, Pco 2, Po 2, 
and oxyhemoglobin saturation were not significantly 
different between groups and within groups at any 
given time (Table I). After induction of anesthesia, 
the hemoglobin values were similar in the 3 groups 
(7.5 + 0.2 g. U I ) ,  and remained stable throughout 
the experiment (7.6 ± 0.6 g. L-i). 
Pump flow was significantly different between the 
groups atT6 (SF 612 ± 144 ml • min; PBF 987 ± 228 
ml.  min; PF 907 ± 153 ml.  min) and T l l  (SF 530 ± 
54 ml • rain; PBF 607 + 117 ml • rain; PF 941 ± 228 
ml. min). 
Maternal mean arterial blood pressure (MABP) 
in the PF group was similar to the 2 other groups in 
regard to repeated-factor ANOVA analysis. Other 
maternal hemodynamic variables remained stable 
throughout he procedure and whatever the fetal 
flow conditions: heart rate, right atrial pressure, 
pulmonary artery pressure, and pulmonary artery 
occlusive pressures (Table II). 
Maternal CO under pulsatile flow started to differ 
from maternal CO under steady flow (Fig. 2) 20 
minutes after the onset of fetal bypass (T5:6.1 + 0.5 
L.  min -1 in SF vs 8.3 ± 0.7 L- min- 1 in PF; P = .07) 
and became significantly different from SF after 30 
minutes of bypass (T6:5.9 _+ 0.5 L .  min q in SF vs 
8.8 ± 0.7 L .  min -~ in PF; P = .01; and vs 7.69 ± 0.9 
L .  min --1 in PBF; P = .05). After T8 and until T11, 
maternal CO was significantly higher in the PF 
group than in the SF group (T l l :  8.7 ± 0.9 L- min q 
4 3 6 Vedrinne t al. 
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Fig. 2. Maternal CO (L-min), evolution, and between 
groups comparison: TO, induction, T3 before bypass; T4 = 
10 min; T6 = 30 min; T8 = 40 rain; Tl l  = 60 rain of 
bypass. *PF versus SF group, P < .05. **PBF group 
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Fig. 3. Maternal systemic vascular esistances (1U), evo- 
lution, and between groups comparison: TO, induction, T3 
before bypass; T4 = 10 min; T6 = 30 rain; T8 = 40 min; 
T11 = 60 min of bypass. *PF versus SF group, P < .05. 
**PBF group versus SF group, P < .05. • PF versus PBF 
group, P < .05. 
vs 5.8 _+ 0.4 L.  min-1; P = .02). In the PBF group a 
drop in maternal CO values was observed after the 
N-NA injection (T7). After T8 and until T l l ,  ma- 
ternal CO in the PBF groups was similar to that of 
the SF group. 
The difference in CO was linked to a significant 
decrease in systemic vascular esistances under pul- 
satile flow conditions. Whereas the systemic vascular 
resistances were similar at the induction of anesthe.- 
sia (TO) and just before bypass (T3) (Fig. 3), they 
differed significantly in the PF versus the SF after 30 
minutes (T6) up until the end of bypass (T l l )  
(respectively, T6:9.1 + 0.6 IU vs 12.7 _+ 1.1 IU; P - 
.02; T l1 :8 .9  _+ 0.5 IU vs 12.9 + 1.2 IU; P = .01). 
After 30 minutes of pulsatile flow (T6), systemic 
vascular esistances in the PBF group were similar 
to those of the PF group but differed significantly 
from those of the SF group (T6:9.3 _+ 0.7 IU in 
PBF; P = .01). In the PBF group, a significant 
increase in systemic vascular resistances was ob- 
served l0 minutes after N-NA infusion (T8:9.3 _+ 
0.7 IU to 12.9 _+ 0.9 IU; P =.05). They remained 
then similar to that of the SF group until the end of 
bypass (Tt 1). 
Pulmonary vascular esistances were not different 
between the groups (repeated-factor ANOVA) 
throughout the procedure. 
The fetal bolus injection of N-NA performed 30 
minutes after the initiation of bypass and followed 
by a continuous infusion induced no instantaneous 
significant increase in systemic blood pressure (T7), 
neither in the ewes nor in the fetuses. 
Maternal injection of ACH at the end of the 
bypass (T12) induced a significant decrease in ma- 
ternal systemic blood pressure in the 3 groups 
(Table IIi). Conversely, fetal injection of ACH after 
minute 40 of bypass was followed by a significant 
drop in fetal systemic blood pressure in the PF 
group (T9, P = .01), a nonsignificant drop in fetal 
systemic blood pressure in the SF group, and no 
changes in fetal systemic blood pressure in the PBF 
group (Table III). 
When comparing maternal endothelin-1 levels, 
there was no significant difference either intra- or 
intergroup (SF: 62.1 _+ 13.2 pg. ml 1; PF: 42 _+ 4.8 
pg- ml-1; PBF: 41.6 _+ 14.9 pg. ml-1). 
Similarly urinary nitrate and nitrite values (SF: 
450 -+ 110 /zmol-L-1; PF: 546 _+ 54 /xmol. L-a; 
PBF: 571 _+ 85 p~mol • L -1) did not reach significant 
difference. 
Discuss ion  
In a previous study on a fetal lamb preparation 
undergoing 30 minutes of bypass, we had made the 
observation that maternal blood pressure under 
fetal pulsatile flow was usually lower than under 
fetal steady flow bypass. 1° The pump flow was 
significantly higher in the pulsatile flow conditions, 
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Table III. Effect on mean arterial pressure of ACH injection in ewes and fetuses 
Ewes Fetuses 
MABP1 MA BP2 P MABP1 MABP2 P 
SF 76.2 -+ 3.8 51.8 ± 3.8 <.004 51.2 -+ 2.5 46.5 -+ 2 
PF  84.9 ± 4.6 54 ± 8.2 <.0001 52.7 +- 1.6 43.6 -+ 2 




All data are mean -+ SEM. 
MABP1, Mean arterial blood pressure before ACH injection; MABP2, mean arterial blood pressure after ACH injection. 
and the role of fetal or placental vascular mediator 
release on fetus hemodynamics had been suggested. 
The aim of the present study was to confirm the 
effects of fetal blood flow characteristics on mater- 
nal blood pressure and to assess maternal blood flow 
and resistances, which were not available in the 
previous study. Because we had demonstrated in
another study 1~ that there was a release of NO from 
the fetal endothelium under pulsatile flow bypass, 
we hypothesized that observed maternal effects, if 
any, might be due to fetal or fetoplacental unit 
synthesis of endothelial autacoids in response to 
different fetal perfusion conditions. 
The use of pulsatile flow during standard cardiac 
operations remains controversial, but several au- 
thors demonstrated a better tissue perfusion, ~8 a 
lower hormonal stress response or "whole body 
inflammatory response, ''I9 and a reduction in the 
occurrence of postoperative hypertension. 2°' 21 In 
this study the maternal hemodynamic differences 
observed between pulsatile and steady flow fetal 
bypass groups disappeared after fetal infusion of 
N-NA, a highly specific inhibitor of NO synthesis. Iv 
This effect suggests the release of NO 22 during fetal 
pulsatile flow bypass. 
NO is synthesized from L-arginine released by en- 
dothelial cells, and it relaxes vascular smooth muscle 
by inducing production of intracellular cyclic 
guanosine monophosphate. NO has only a local effect 
because it is inactivated by hemoglobin and thus 
disappears within a few seconds. However, its constant 
synthesis and release by endothelial cells maintains a
constant vasodilator tone on the whole vascular sys- 
tem. 22 At this moment, here is no direct evidence that 
bypass changes modify NO production. It has been 
demonstrated in vitro in isolated arterial segments hat 
high shear stress in arterial wall stimulates the endo- 
thelial cell synthesis of NO. I3' 14 Thus blood vessels are 
submitted on 1 hand to mechanical stress related to 
the transmural pressure xerted on their walls and on 
the other hand to blood flow changes. 23An increase in 
blood flow is followed by relaxation of the vessel, 
which tends to counteract the shear stress, through an 
increase in NO production and a decrease in endothe- 
lin-1 liberation. 24 
Normally the placenta receives 40% (200 
ml. kg -1 • min -1) of the total biventricular fetal output 
(450 ml .kg 1.min-1),25 and pulsatile bypass was 
found to maintain the placental perfusion within phys- 
iologic limits in our previous study. 1° Moreover, 
plasma levels, urinary excretion, and metabolic pro- 
duction of cyclic guanosine monophosphate are in- 
creased in gravid rats and Conrad and colleagues 16
postulated that endogenous NO may mediate this 
changes. The authors also identified an increased NO 
biosynthesis during pregnancy. 26NO synthase nzyme 
was recently identified in the human placental villous 
vascular tree, and NO appears to be involved in 
maintaining basal tone and alleviating the effect of 
vasoconstrictors onfetoplacental circulation, a7 So, the 
earlier experiences under steady flow bypass in fetal 
lambs demonstrated fetal death to be related to hyper- 
capnia and hypoxia, secondary to placental vasocon- 
striction.S, 9 Pulsatile flow may have acted as a contin- 
uous stimulus on the endothelial cells thus upholding 
the usual high placental production level of NO. It 
remains unclear why the apparently ower fetal urinary 
nitrate level in the SF group than in either PF or PBF 
group did, however, not reach significance; but mater- 
nal blood and urinary nitrate measurements were not 
available at the time of the study. 
ACH injection in the fetus induced a significant 
decrease in MABP only in the PF group and a 
nonsignificant drop in the SF group. These findings 
support the hypothesis that under PF the basal 
production level of NO is higher than in the 2 other 
groups: despite the circuit priming volume and 
hemodilution, the injection of endothelium-depen- 
dent ACH may have induced a significant liberation 
of NO generating the blood pressure drop. No 
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changes in systemic blood pressure were observed in 
the PBF group, confirming in this case the efficient 
blockade of fetal NO synthase. 
Maternal ACH injection induced a significant 
drop in maternal  MABP in all 3 groups of animals. 
Even though N-NA may cross the fetoplacental 
barrier 28 and although it is conceivable that the 
bolus administration of ACH may have over- 
whelmed the inhibitory effects of fetal N-NA injec- 
tion, maternal  hemodynamic changes in the PBF 
group could not be explained only by maternal  NO 
synthesis inhibition, raising the issue of other vaso- 
active substances release during pulsatile perfusion. 
Endothel in-1 is a powerful long-acting calcium- 
dependent  vasoconstrictor p oduced by endothelial 
cells. 29 Conventional  cardiopulmonary bypass in- 
creases the plasma endothelin-1 level. 2° Endothe-  
lin-1 binding sites have also been described 3° in 
trophoblast and in human placental blood vessels. In 
the pregnant rat, endothelin-1 has been described 
either as a vasodilator or a vasoconstrictor agent, 
depending on the injection dose, the pregnant term, 
and the nature of endothel in receptor affinity. How- 
ever in this study, endothelin-1 levels were similar in 
the 3 groups of fetuses. 
In conclusion, fetal pulsatile bypass induced an 
increase in maternal  CO as the result of a decrease 
in vascular peripheric resistances and a positive 
balance release of vasodilatator factors like NO. 
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